“Mover of Good Pharmacy Practices in Public Health Facilities Convene for Annual Pharmacist Training”


       Since 2011, the Department of Health (DOH) has been deploying licensed pharmacists to its regional health offices and Local Government Units (LGUs) to initially monitor the movement of health commodities provided to health facilities. During the course of program implementation, however, the Pharmaceutical Division (PD) realized the need to go beyond the provision of essential medicines and expand the goals towards improving Supply Chain Management (SCM) and community pharmacy services. Technical assistance with monitoring health commodities was established in LGUs from 2011-2015.


         In support of the deployment of the PHPs, the Pharmaceutical Division (PD) through the Program Implementation and Monitoring Unit (PIMU) has been conducting capacity building by providing our pharmacists with short courses relevant to the demands in their field.


       In time with the execution of President Duterte’s directive to bridge the gap on access to medicines, the revitalization of the “Botika ng Bayan” is being pursued by the DOH. The establishment of the FOURmula One Plus Botika ng Bayan and Botika ng Bayani (F1+ BNB and BNBi) will not only provide additional medicines but will also result in improved public health pharmacy services.  The DOH will make these services available through the Public Health Pharmacists (PHPs) to be assisted by the Pharmacy Assistants (PAs) who will be deployed to the rural health units and health centers.

       This year’s annual training was intended to provide PHPs with the knowledge and skills needed to manage F1+ BNB and BNBi. It highlighted the technical, social and administrative concepts required to effectively facilitate access to medicines and health services in the context of the government system. The PD-PIMU together with the team of Ms. Leonila Ocampo, PD hired consultant for Botika ng Bayan (BNB), conceptualized this year’s theme entitled “Potentiating the Roles of the Pharmacists and the Pharmacy Support Workforce in the Public Health Facilities”. The 1st batch of PHPs was convened in Nature’s Village Resort in Talisay, Negros Occidental July 25 - 26, 2018.


        The 2-day event started with the orientation on the pending Bill on Universal Healthcare and the DOH’s Health Sector Reforms through the execution of FOURmula One Plus (F1+) by the Chief of Pharmaceutical Division, Dr. Anna Melissa S. Guerrero.  After which, Dr. Irene Florentino-Fariñas discussed the Philippine Medicines Policy 2018-2022, wherein the revitalization of the F1+ BNB and BNBi will bridge the gap access to medicines and provision of pharmaceutical care.

      The 2nd part of the program was the F1+ BNB and BNBi operational framework and the proposed roles and its processes.  Mr. Isaac Linatoc presented the module on promoting workplace integrity, safety and security through adherence to Good Storage and Distribution Pharmacy Practices. 


        On day 2, Mr. Cristan Agaceta discussed the module entitled demonstrating professionalism and earning the public trust in the delivery of medicines in public health facilities.  Then, Ms. Ocampo talked about the ethical, legal and regulatory considerations in the provision of pharmacy practices in the public health setting.

        The 3rd part of this year’s training consisted of updates on the different PD programs and regional activities. For the rational use of medicines, Ms. Joyce Ann Ceria-Pereña presented the updates on the Philippine National Formulary as well as its process of inclusion, deletion and exemption. This was by Ms. Lora Alaine Raymundo who discussed the Antimicrobial Stewardship Program (AMSP) for primary care and the role of Local Chiefs Executives (LCEs) in the proposed  AMS intervention.


        At the end of the course, Dr. Guerrero addressed the different concerns of the delegates attending the Batch 1 PHP Annual Training from Regions II, III, VI, VII, XI, XII, CAR and NCR, “The Pharmacists are now being felt in the grassroots level particularly in the rural health centers. The LCEs are becoming aware that Pharmacists are an integral part of their team in delivering quality healthcare and addressing the need for quality essential medicines.”

        All PHPs earned 14 Continuing Pharmacy Education (CPE) Units each for attending all courses with certificate number 2018-027-1227_. The training had a positive feedback from the participants with an average score of 3.56 with 4, being the highest score using the DOH-PD training evaluation level 2.


        The 2nd batch will be conducted on the 15th to 16th of August in Cebu City. PHPs from regions I, II, IVA, IVB, V, VI, IX, X, CARAGA and ARMM are expected to attend and be oriented on the different modules similar to the 1st batch.



[11-21-19] - Deleted Chlorpromazine 50 mg tablet (as hydrochloride) and 25 mg/mL (as hydrochloride), 1 mL ampule (IM, IV) based on this Document : { p.9}

[11-21-19] - Deleted Heparin 1000 IU/mL and 5000 IU/mL, 30 mL vial (IV infusion, SC) (bovine origin) based on this Document : { p.22}

[08-30-19] - Deleted Conjugated Equine Estrogen (dual entry): { p.11 }

[08-30-19] - Deleted 7‐ valent suspension, pre‐filled syringe (IM) in Pneumoccocal Conjugate Vaccine : { p.37 }

[08-05-19] - Clarification on the specification of Levothyroxine in the Philippine National Formulary as per DM No. 2019-0294 : { p.23 }

[07-23-19] - Added Hypertonic lactate solution as per DM No. 2019-0287 : { p.23 }

[07-23-19] - Added Iodixanol as per DM No. 2019-0287 : 652 mg/mL (equivalent to 320 mg iodine) solution for injection, 50 mL and 100 mL vial and 550 mg/mL (equivalent to 270 mg iodine) solution for injection, 50 mL vial : { p.24 }

[07-05-19] - Revision in the specifications of Famotidine as per DM No. 2019-0286 : Changed from 10 mg/mL, 2 mL ampule/vial (IM, IV) to 20 mg powder/lyophilized powder for injection, ampule/vial : { p.18}

[07-05-19] - Added Bedaquiline fumarate as per DM No. 2019-0250 : 100 mg tablet : { p.5 }

[07-05-19] - Added Delamanid as per DM No. 2019-0250 : 50 mg film-coated tablet : { p.12 }

[07-05-19] - Added Polymixin B sulfate as per DM No. 2019-0250 : 500,000 Units powder for solution for injection (Intrathecal/IM/TV), 5 mL vial : { p.37 }

[07-05-19] - Added Levobupivacaine as per DM No. 2019-0250 : 5 mg/mL solution for injection, 10 mL ampule : { p.27 }

[07-05-19] - Revision in the specifications of Epinephrine as per DM No. 2019-0251 : Changed from 1 mg/mL, 1 mL ampule (IM, SC) to 1 mg/mL, 1 mL ampule (IV, IM, SC) : { p.17}

[06-11-19] - Added Neostigmine (Re-inclusion, as per DM No. 2019-0206) : 500 mcg/mL solution for injection (IM/IV/SC), 1 mL ampule : { p.32 }

[06-04-19] - Revision in the specifications of multivitamins and amino acid solutions for infants in the Philippine National Formulary, as per DM No. 2019-0196 :

[Multivitamins] Vitamin D for infants (per 1 mL drops) and Children (per 5 mL syrup) changed from (200 IU (5 mcg)) to (200-400 IU (5-10 mcg)) ; Vitamin C for adult (per tablet/capsule) changed from (65 - 80 mg) to (60 - 80 mg) : { p.31-30}

[Amino Acid Solutions for infants] Protein changed from (20 - 50 g including taurine) to (5 - 10 g including taurine) ; Calories changed from (80 - 150 kcal) to (20 - 40 kcal) { p.2}

[01-04-19] - Clarification on the specifications of lactulose in the Philippine National Formulary, as per DM No. 2019-0150 : changed from 3.3 g/5 mL syrup to 3.3 g/5 mL (3.35 g/5 mL) syrup : { p.26}

[04-30-19] - Added Levetiracetam: Oral: 250 mg, 500 mg, 750 mg, and 1 g film coated tablet; Inj.: 500 mg/5 mL (100 mg/mL) concentrate solution for IV infusion, 5 mL vial; Solution:
100 mg/mL oral solution, 100 mL and 300 mL bottle { p.27 }

[04-30-19] - Added Memantine: Oral: 5 mg and 10 mg film coated tablet { p.28 }

[04-30-19] - Added Rifapentine: Oral: 150 mg film coated tablet { p.38 }

[02-22-19] - Added new volume for Paclitaxel ( 6 mg/ml, 16.7 mL IV/IV infusion) { p.34 }

[01-04-19] - Added Epoetin Alfa (Re-inclusion, as per DM No. 2018-0426) : Sterile Solution with 1.5%, 2.3% and 4.25% dextrose, 2 L and 5 L bottle/bag : { p.35 }


[12-18-18] - Added Epoetin Alfa (Re-inclusion, as per DM No. 2018-0418) : 4000 IU/mL solution for injection, 1 mL vial (IV, SC) : { p.17 }